Outcomes and complications of heart failure with iron deficiency anemia: a nationwide analysis.

Q2 Medicine Hospital practice (1995) Pub Date : 2024-08-01 Epub Date: 2024-04-02 DOI:10.1080/21548331.2024.2337615
Abdulmajeed Alharbi, Momin Shah, Nahush Bansal, Allison Franz, Eun Seo Kwak, Anas Alsughayer, Mohammed Mhanna, Ayman Salih, Abdelrhman Mohamed, Qutaiba Qafisheh, Ragheb Assaly
{"title":"Outcomes and complications of heart failure with iron deficiency anemia: a nationwide analysis.","authors":"Abdulmajeed Alharbi, Momin Shah, Nahush Bansal, Allison Franz, Eun Seo Kwak, Anas Alsughayer, Mohammed Mhanna, Ayman Salih, Abdelrhman Mohamed, Qutaiba Qafisheh, Ragheb Assaly","doi":"10.1080/21548331.2024.2337615","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Heart failure is a pressing public health concern, affecting millions in the United States and projected to rise significantly by 2030. Iron deficiency, prevalent in nearly half of ambulatory heart failure patients, contributes to anemia and diminishes patient outcomes. In this study, we aim to evaluate the impact of iron deficiency anemia on acute heart failure hospitalizations outcomes.</p><p><strong>Methods: </strong>Utilizing the 2019 National Inpatient Sample (NIS) database, a retrospective observational study assessed 112,864 adult patients hospitalized with heart failure and 7,865 cases also had a concomitant diagnosis of iron deficiency anemia (IDA).</p><p><strong>Results: </strong>Among 112,864 heart failure hospitalizations in 2019, approximately 7% had concomitant iron deficiency anemia (IDA). Heart failure patients with IDA exhibited distinct demographic characteristics, with females comprising 51.1% (<i>p</i> < 0.01) and higher rates of complicated hypertension (<i>p</i> < 0.01), complicated diabetes (<i>p</i> < 0.01), and peripheral vascular disease (<i>p</i> < 0.01). Adjusted mean LOS for patients with IDA was significantly longer at 1.31 days (95% CI 0.71-1.47; <i>p</i> < 0.01), persisting in both HFpEF and HFrEF subgroups. While total hospital charges were comparable in HFpEF, HFrEF patients with IDA incurred significantly higher charges ($13427.32, 95% CI: 1463.35-$25391.29, <i>p</i> = 0.03) than those without IDA. Complications such as atrial fibrillation and acute kidney injury were notably more prevalent in HFpEF and HFrEF patients with IDA.</p><p><strong>Conclusion: </strong>The study highlighted that iron deficiency in heart failure patients leads to extended hospital stays, increased costs, and heightened risks of specific complications, particularly in HFrEF. Our study emphasized the implications of IDA in patients with heart failure ranging from prolonged hospitalizations and increased costs. Addressing iron deficiency is crucial, given its substantial impact on heart failure hospitalizations and outcomes, emphasizing the need for proactive diagnosis and management.</p>","PeriodicalId":35045,"journal":{"name":"Hospital practice (1995)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital practice (1995)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21548331.2024.2337615","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Heart failure is a pressing public health concern, affecting millions in the United States and projected to rise significantly by 2030. Iron deficiency, prevalent in nearly half of ambulatory heart failure patients, contributes to anemia and diminishes patient outcomes. In this study, we aim to evaluate the impact of iron deficiency anemia on acute heart failure hospitalizations outcomes.

Methods: Utilizing the 2019 National Inpatient Sample (NIS) database, a retrospective observational study assessed 112,864 adult patients hospitalized with heart failure and 7,865 cases also had a concomitant diagnosis of iron deficiency anemia (IDA).

Results: Among 112,864 heart failure hospitalizations in 2019, approximately 7% had concomitant iron deficiency anemia (IDA). Heart failure patients with IDA exhibited distinct demographic characteristics, with females comprising 51.1% (p < 0.01) and higher rates of complicated hypertension (p < 0.01), complicated diabetes (p < 0.01), and peripheral vascular disease (p < 0.01). Adjusted mean LOS for patients with IDA was significantly longer at 1.31 days (95% CI 0.71-1.47; p < 0.01), persisting in both HFpEF and HFrEF subgroups. While total hospital charges were comparable in HFpEF, HFrEF patients with IDA incurred significantly higher charges ($13427.32, 95% CI: 1463.35-$25391.29, p = 0.03) than those without IDA. Complications such as atrial fibrillation and acute kidney injury were notably more prevalent in HFpEF and HFrEF patients with IDA.

Conclusion: The study highlighted that iron deficiency in heart failure patients leads to extended hospital stays, increased costs, and heightened risks of specific complications, particularly in HFrEF. Our study emphasized the implications of IDA in patients with heart failure ranging from prolonged hospitalizations and increased costs. Addressing iron deficiency is crucial, given its substantial impact on heart failure hospitalizations and outcomes, emphasizing the need for proactive diagnosis and management.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
缺铁性贫血心力衰竭的预后和并发症:全国性分析。
前言心力衰竭是一个紧迫的公共卫生问题,在美国影响着数百万人,预计到 2030 年将大幅上升。近一半的非卧床心衰患者普遍缺铁,缺铁会导致贫血并降低患者的预后。在这项研究中,我们旨在评估缺铁性贫血对急性心力衰竭住院治疗结果的影响:利用 2019 年全国住院患者抽样(NIS)数据库,对 112864 名因心衰住院的成年患者进行了回顾性观察研究,其中 7865 例患者同时被诊断为缺铁性贫血(IDA):在2019年住院的112864名心衰患者中,约7%同时患有缺铁性贫血(IDA)。与无缺铁性贫血的患者相比,有缺铁性贫血的心衰患者表现出明显的人口统计学特征,其中女性占51.1%(p p p p p = 0.03)。心房颤动和急性肾损伤等并发症在患有 IDA 的高频心力衰竭和高频心力衰竭患者中的发病率明显更高:该研究强调,心衰患者缺铁会导致住院时间延长、费用增加以及特定并发症风险升高,尤其是在 HFrEF 患者中。我们的研究强调了IDA对心衰患者的影响,包括住院时间延长和费用增加。鉴于铁缺乏对心衰住院和预后的重大影响,解决铁缺乏问题至关重要,这也强调了积极诊断和管理的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hospital practice (1995)
Hospital practice (1995) Medicine-Medicine (all)
CiteScore
2.80
自引率
0.00%
发文量
54
期刊最新文献
An insight into the updated pharmacotherapy of metabolic-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatohepatitis (MASH) in lean individuals: a review. Chest tube size selection for pleural effusion: from the perspective of thoracic surgeons and pulmonologists. Prescription for crisis: the compounding effect of community drug shortages on Lebanon's healthcare system. Outcomes and complications of heart failure with iron deficiency anemia: a nationwide analysis. Benign acute myositis in an adult: case-based review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1